NCT06323785

Whole-body Hyperthermia for Depression

Name: Clinical Trial NCT06323785
Creator: University of Zurich
Keywords: Major Depressive Disorder, Active whole-body hyperthermia, device, clinical trial, Switzerland

Randomised Sham-controlled Trial of Whole-body Hyperthermia for Depression

University of Zurich·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Major Depressive Disorder
Drug/Device/Intervention: Active whole-body hyperthermia
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: University of Zurich
Location: Zurich, Switzerland

Timeline & enrollment

Phase: N/A
Start date: Apr 30, 2024
End date: Mar 01, 2026
Enrollment: 30 participants

Primary outcome

Hamilton Rating Scale for Depression (HAMD-17; minimum: 0, maximum: 68, higher scores indicate higher depression)

Summary

The goal of this clinical trial is to test the efficacy of whole-body hyperthermia in major depression. The main question it aims to answer is:  • Does whole-body hyperthermia alleviate symptoms of depression?  Participants will be randomised to sham or active whole-body hyperthermia. The study will last 6 weeks during which five visits will take place. Depression will be measured repeatedly and biological mechanisms will be investigated.

ICD-10 classifications

Recurrent depressive disorderRecurrent depressive disorder, unspecifiedDepressive conduct disorderOther recurrent depressive disordersRecurrent depressive disorder, current episode moderate

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06323785
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06323785 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Zurich and is currently Recruiting. The study focuses on Major Depressive Disorder. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.